Sacheerome Earnings Call Transcript: Key Takeaways
H1 FY27 steady: income +9.84% to ₹85.92 Cr, PAT +12.38% to ₹16.79 Cr, EBITDA margin 27.57%. YEIDA plant in trial, commercial output awaits certificates. Capex and utilisation answers evasive.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
31 announcements with these filters
H1 FY27 steady: income +9.84% to ₹85.92 Cr, PAT +12.38% to ₹16.79 Cr, EBITDA margin 27.57%. YEIDA plant in trial, commercial output awaits certificates. Capex and utilisation answers evasive.
H1 FY27: total income ₹8,592L (+9.84% YoY), EBITDA ₹2,369L (+12.27%), PAT ₹1,679L (+12.38%), EBITDA margin 27.57%. YEIDA trial production began Sep 2026.
Sacheerome reported H1 FY27 total income of Rs 8,592 Lakh, up 9.84%, and PAT up 12.38%. Its YEIDA facility began trial production in September 2026.
Sacheerome reported no deviation in IPO fund utilisation for the half year ended 30 September 2026. The filing is a routine Reg 32 proceeds statement.
Sacheerome Ltd reported revenue from operations of ₹84.5 Cr (+10.3% YoY) and net profit of ₹16.8 Cr (+12.8% YoY) for H1 FY27.
Sacheerome Limited intimated a board meeting scheduled for 31-Oct-2026 to consider unaudited half-yearly financial results for September 2026. The meeting has not yet been held; agenda items are proposed only.
Sacheerome Limited reported H1 FY27 revenue of ₹84.48 Cr. The company completed its new YEIDA facility, which commenced trial production in September 2026.
Sacheerome Limited has filed a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.
Sacheerome Limited has commenced trial production at its new manufacturing facility located at Sector-32, YEIDA, U.P. Installation and commissioning of the plant are complete.
Sacheerome Limited held its 34th Annual General Meeting on September 24, 2026, via video conferencing to transact the planned agenda items.
Sacheerome Limited has issued the notice for its 34th Annual General Meeting, scheduled to be held on September 24, 2026, via video conferencing.
Sacheerome Limited has delayed the commissioning of its new manufacturing unit from August 2026 to September 2026 due to vendor issues. Commercial operations are expected to commence shortly.
Sacheerome Limited's board approved a revised timeline for the implementation of a new manufacturing unit. No financial details were disclosed regarding this schedule change.
Sacheerome Limited has scheduled a board meeting for August 11, 2026, to discuss other business matters.
Sacheerome Limited released its Q1 FY27 business update, highlighting operational metrics, current manufacturing capacity, and the upcoming facility in YEIDA, Uttar Pradesh.
Sacheerome Limited reported record FY26 results with Revenue of ₹152.39cr and 26.02% EBITDA margin. Strategy focuses on a 4x capacity expansion via the new YEIDA facility.
Sacheerome Limited filed its quarterly compliance certificate confirming the maintenance of a Structured Digital Database. This routine regulatory filing validates adherence to SEBI insider trading regulations.
Sacheerome Limited delivered robust H2 FY26 performance with Revenue at ₹7,582 Lakhs and PAT at ₹1,350 Lakhs, driven by its dual fragrance and flavour segments and B2B FMCG focus.
Sacheerome Limited confirmed no deviation in utilizing ₹61.61 Crore raised via IPO. Funds are being deployed for setting up a manufacturing facility and corporate purposes.
Sacheerome Limited disclosed its related party transactions for the half-year ended March 31, 2026. The filing complies with SEBI listing regulations regarding periodic transparency.
Sacheerome Limited reported FY26 Total Income of ₹156.29 Crore, marking 44% YoY growth. Net profit rose 78%, driven by margin expansion and strong domestic demand.
Sacheerome Limited appointed M/S T R CHADHA & CO LLP as Internal Auditors for FY 2026-27. This regulatory appointment strengthens the company's internal control and governance framework.
Sacheerome Limited reported a total annual income of ₹156.29 Crore for the financial year 2026. This reflects substantial growth and operational stability for investors.
Sacheerome Ltd reported revenue from operations of ₹75.8 Cr (+32.7% YoY) and net profit of ₹13.5 Cr (+51.7% YoY) for H2 FY26.
Sacheerome Limited reported annual revenue of ₹152.39 Crore for FY2026. The audited results show significant growth, reflecting strong operational performance for investors.
Sacheerome Limited scheduled a board meeting for May 25, 2026, to approve audited annual financial results. The trading window remains closed until May 27.
Sacheerome Limited filed its Monitoring Agency Report for the quarter ended March 31, 2026. The report tracks utilization of ₹58.25 Crore net IPO proceeds.
Sacheerome Limited revised the timeline for its new manufacturing unit in Uttar Pradesh to August 2026. Delays cite global geopolitical conditions affecting material and manpower availability.
Sacheerome Limited submitted an undertaking for the non-applicability of the quarterly Corporate Governance Report for the quarter ended March 31, 2026. As an SME Exchange listed entity, it is exempt from these requirements under SEBI (LODR) Regulations, 2015.
Sacheerome Limited informed the stock exchange that it does not qualify as a 'Large Corporate' for the financial year 2026. This regulatory filing complies with the SEBI framework for debt security issuance by large entities.